Citations

Showing 10 of 108083 citations.

The prevalence of Eustachian tube dysfunction symptoms in patients with chronic rhinosinusitis
Tangbumrungtham, Navarat , Patel, Vishal S. , Thamboo, Andrew , Patel, Zara M. , Nayak, Jayakar V. , Ma, Yifei , Choby, Garret , Hwang, Peter H.

Mayo Clinic

International Forum of Allergy & Rhinology | December 11, 2017 | Volume: 8 | Issue: 5 | Pages: 620-623

10.1002/alr.22056 | PMID 29227048 Get It

Background While Eustachian tube dysfunction (ETD) is a known comorbidity of chronic rhinosinusitis (CRS), the prevalence of ETD symptoms in the CRS population is poorly understood. We sought to determine the cross‐sectional prevalence of ETD in patients with CRS using the validated Eustachian Tube Dysfunction Questionnaire (ETDQ‐7) and to correlate ETDQ‐7 scores with 22‐item Sino‐Nasal Outcome Test (SNOT‐22) scores, endoscopy scores, and computed tomography (CT) scores. Methods A total of 101 patients with confirmed CRS completed the ETDQ‐7 and SNOT‐22 at their initial visit to our rhinology clinic. Lund‐Mackay CT and Lund‐Kennedy endoscopy scores were also obtained. Spearman's correlation coefficient (ρ) was calculated. Results Among the 101 patients, 49 patients (48.5%) had an ETDQ‐7 score of ≥14.5, signifying clinically significant ETD. The mean ± standard deviation (SD) ETDQ‐7 score of the entire cohort was 17.8 ± 10.1. There was a moderately strong correlation between ETDQ‐7 and the SNOT‐22 ear subdomain (ρ = 0.691, p < 0.001). The correlation coefficient between ETDQ‐7 and total SNOT‐22 scores was ρ = 0.491 ( p < 0.001), indicating moderate correlation. ETDQ‐7 scores were poorly correlated to objective measures of sinonasal disease, including Lund‐Mackay CT score (ρ = −0.055, p = 0.594) and Lund‐Kennedy endoscopy score (ρ = −0.099, p = 0.334). Conclusion Symptoms of ETD are highly prevalent among patients with CRS as documented by patient‐reported outcome measures. The correlation between ETDQ‐7 scores and SNOT‐22 ear subdomain scores is moderately strong, while the correlation between ETDQ‐7 scores and SNOT‐22 scores is moderate. ETD severity does not correlate with CT score or nasal endoscopy score.
Diagnostic Evaluation of the Knee in the Office Setting Using Small‐Bore Needle Arthroscopy
Patel, Karan A. , Hartigan, David E. , Makovicka, Justin L. , Dulle, Donald L., Chhabra, Anikar , Patel, Karan , Chhabra, Anikar

Mayo Clinic

Arthroscopy Techniques | December 11, 2017 | Volume: 7 | Issue: 1 | Pages: No page available

10.1016/j.eats.2017.08.044 | PMID 29379709 Get It

Abstract Arthroscopy is currently the gold standard for diagnosing intra‐articular knee pathology. Magnetic resonance imaging (MRI) can be a clinical adjunct for diagnosis; however, it is not without its shortcomings. Although highly accurate, even advanced imaging misdiagnoses the condition in 1 in 14 patients with regard to anterior cruciate ligament pathology. Previous studies have indicated that MRI fails to identify meniscal pathology when one exists in 1 of every 10 cases, and diagnoses pathology when pathology truly does not exist in 1 of every 5 patients. In‐office arthroscopy offers an alternative to formal diagnostic arthroscopy, with reduced cost and risk of complications. This is a technique article that discusses the use of small‐bore needle arthroscopy in the office setting. Technique Video video See video under supplementary data.
Management of Adolescent–Parent Dyads’ Discordance for Willingness to Participate in a Reproductive Health Clinical Trial
Francis, Jenny , Fraiz, Lauren Dapena, Roche, Ariel M. de, Catallozzi, Marina , Breitkopf, Carmen Radecki , Rosenthal, Susan L. , Francis, Jenny K R , Radecki Breitkopf, Carmen, Roche, Ariel M. de

Mayo Clinic

Journal of Empirical Research on Human Research Ethics | December 11, 2017 | Volume: 13 | Issue: 1 | Pages: 42-49

10.1177/1556264617745409 | PMID 29226745 Get It

The objective of this study is to understand the resolution of discordance between adolescent–parent dyads about participation in research. Adolescent (14-17 years) and parent dyads were recruited from NYC pediatric clinics to assess attitudes toward research participation. A subset of dyads participated in videotaped discussions about participation in a hypothetical study. Videos from dyads that held strongly discordant opinions about participation ( n = 30) were content-coded and analyzed using a thematic framework approach. Strategies used to resolve discordance included asserting authority, granting autonomy, or recognizing inaccurate assumptions using a variety of communication behaviors. Missed opportunities to enroll initially discordant dyads may be avoided by allowing time for adolescents and parents to elicit information, clarify a situation, or convince the other.
Incidence of Osteoporosis-Related Complications Following Posterior Lumbar Fusion
Bjerke, Benjamin T., Zarrabian, Mohammad , Aleem, Ilyas , Fogelson, Jeremy L. , Currier, Bradford L. , Freedman, Brett A. , Bydon, Mohamad , Aleem, Ilyas S, Nassr, Ahmad

Mayo Clinic

Global Spine Journal | December 10, 2017 | Volume: 8 | Issue: 6 | Pages: 563-569

10.1177/2192568217743727 | PMID 30202709 Get It

Study Design: Retrospective review. Objectives: This study investigates the prevalence of adverse postsurgical events, or osteoporosis-related complications (ORCs), following spinal fusion. Methods: Patients undergoing primary posterior thoracolumbar or lumbar fusion by 1 of 2 surgeons practicing at a single institution were analyzed from 2007 to 2014. ORCs were defined in one of the following categories: revision surgery, compression fracture, proximal junctional kyphosis, pseudarthrosis, or failure of instrumentation. Patients with a bone mineral density of the hips and/or spine performed within 1 year of the index procedure were included. Patients were stratified into normal bone density, osteopenia, and osteoporosis using WHO guidelines. Patients were excluded if they were younger than 18 years at the time of surgery, with infection, malignancy, skeletal dysplasia, neuromuscular disorders, concomitant or staged anterior-posterior procedure, or fusion performed because of trauma. Results: Out of 140 patients included, the prevalence of normal bone density was 31.4% (44/140), osteopenia 58.6% (82/140), and osteoporosis 10.0% (14/140). There were no differences between groups for gender, age, body mass index, and interbody device rate. The overall prevalence of ORCs was 32.1% (45/140). By group, there was a prevalence of 22.7% (10/44), 32.9% (27/82), and 50.0% (7/14) for normal bone density, osteopenia, and osteoporosis, respectively. These differences were significantly higher for both the osteopenia and osteoporosis groups. Conclusions: Patients with T scores below −1.0 undergoing posterior lumbar fusion have an increased prevalence of ORCs. Consideration of bone density plays a crucial role in patient selection, medical management, and counseling patient expectations.
Ectopic expansion of engineered human liver tissue seeds using mature cell populations
Naugler, Willscott E. , Hickey, Raymond D, Hickey, Raymond

Mayo Clinic

Hepatology | December 9, 2017 | Volume: 67 | Issue: 6 | Pages: 2465-2467

10.1002/hep.29718 | PMID 29222915 Get It

Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1‐PRKACA fusion
Graham, Rondell P. , Lackner, Carolin , Terracciano, Luigi , González-Cantú, Yessica Margarita , Maleszewski, Joseph J. , Greipp, Patricia T. , Simon, Sanford M. , Graham, Rondell P , Greipp, Patricia T , Simon, Sanford M , Torbenson, Michael

Mayo Clinic

Hepatology | December 9, 2017 | Volume: 68 | Issue: 4 | Pages: 1441-1447

10.1002/hep.29719 | PMID 29222914 Get It

Fibrolamellar carcinomas are characterized by activation of protein kinase A, a kinase composed of catalytic and regulatory subunits. PRKACA encodes a catalytic subunit of protein kinase A, and almost all fibrolamellar carcinomas have a heterozygous 400‐kb deletion that leads to the fusion of DNAJB1 and PRKACA . The resulting DNAJB1‐PRKACA fusion transcript is believed to activate protein kinase A by dysregulation of the catalytic portion of the protein. In contrast, PRKAR1A encodes one of the regulatory subunits of protein kinase A. We hypothesized that loss of function of this regulatory unit could also lead to protein kinase A activation and thus to fibrolamellar carcinoma. Because PRKAR1A mutations underlie the Carney complex, we searched for liver tumors in individuals with the Carney complex. We identified 3 individuals with fibrolamellar carcinomas and a personal history of the Carney complex. All three tumors displayed the typical morphology of fibrolamellar carcinoma and were positive for arginase, cytokeratin 7, and cluster of differentiation 68. Fluorescence in situ hybridization was negative for PRKACA rearrangements. However, PRKAR1A sequencing identified pathogenic mutations in two of two cases with successful sequencing. In addition, all three cases were negative for PRKAR1A protein expression, consistent with inactivation of this key regulatory unit of protein kinase A. We also identified one additional fibrolamellar carcinoma in an individual without a documented history of the Carney complex who was negative for PRKACA rearrangements but had loss of PRKAR1A protein expression as well as PRKAR1A mutations. Conclusion : Fibrolamellar carcinoma can be part of the Carney complex; in this setting, fibrolamellar carcinomas have inactivating PRKAR1A mutations instead of the DNAJB1‐PRKACA fusion gene found in sporadic fibrolamellar carcinomas, providing an alternate means for activation of protein kinase A. (H epatology 2017).
Longitudinal Association Between Brain Amyloid-Beta and Gait in the Mayo Clinic Study of Aging
Wennberg, Alexandra , Lesnick, Timothy G. , Savica, Rodolfo , Hagen, Clinton E., Roberts, Rosebud O., Hollman, John H. , Vemuri, Prashanthi , Jack, Clifford R. , Petersen, Ronald C. , Mielke, Michelle M. , Wennberg, Alexandra M V, Jack, Clifford R , Wennberg, Alexandra M V , Mielke, Michelle M , Hollman, John , Vemuri, Prashanthi , Schwarz, Christopher G. , Knopman, David S.

Mayo Clinic

The Journals of Gerontology: Series A | December 9, 2017 | Volume: 73 | Issue: 9 | Pages: 1244-1250

10.1093/gerona/glx240 | PMID 29236984 Get It

The study of intravitreal drug pharmacokinetics: does it matter? and if so, how?
Stewart, Michael W.

Mayo Clinic

Expert Opinion on Drug Metabolism & Toxicology | December 9, 2017 | Volume: 14 | Issue: 1 | Pages: 5-7

10.1080/17425255.2018.1416098 | PMID 29221430 Get It

Spheroid‐type of AL amyloid deposition associated with colonic adenocarcinoma: A case report with literature review
McCroskey, Zulfia , Piao, Yingchao, Belcheva, Anna, Truong, Luan D., Kurtin, Paul J. , Ro, Jae Y. , Kim, Moonjoo

Mayo Clinic

Pathology International | December 9, 2017 | Volume: 68 | Issue: 2 | Pages: 123-127

10.1111/pin.12618 | PMID 29222812 Get It

We report a colonic adenocarcinoma associated with diffuse submucosal deposition of a peculiar spheroid‐type amyloid identified in the colon, terminal ileum, and appendix. A 65‐year‐old woman with past medical histories of hypertension, and chronic obstructive pulmonary disease, presented to the emergency room with cramping abdominal pain and nausea. A computed tomography (CT) scan of abdomen showed right colonic volvulus. Emergency right hemicolectomy was performed. The specimen showed colonic adenocarcinoma with focal submucosal invasion (pT1) arising from a villotubular adenoma. A diffuse submucosal spheroid‐type amyloid deposition (resembling corpora amylacea‐like structures with Liesegang ring formation) was identified in the colon, ileum, and appendix. Electron microscopy examination of this unusual spheroidal‐type material further confirmed the presence of amyloid fibrils. Analysis by liquid chromatography–mass spectrometry detected AL (lambda) type amyloidosis in this specimen. Tests for monoclonal gammopathy were not performed because patient consent was not obtained. In tissue section evaluation, however, no plasma cell neoplasm was identified. Cases with isolated AL amyloid deposition in the gastrointestinal tract have been reported rarely, and there is no case report of colonic adenocarcinoma associated with primary amyloid deposition in the English literature.
Milder disease stage in patients with primary biliary cholangitis over a 44‐year period: A changing natural history
Perez, Carla Fiorella Murillo, Goet, Jorn , Lammers, Willem J. , Gulamhusein, Aliya , Buuren, Henk R. van , Ponsioen, Cyriel Y. , Carbone, Marco , Mayo, Marlyn J. , Floreani, Annarosa , Parés, Albert , Nevens, Frederik , Bruns, Tony , Thorburn, Douglas , Lindor, Keith D. , Zachou, Kalliopi , Poupon, Raoul, Verhelst, Xavier , Janssen, Harry L.A. , Group, on behalf of the GLOBAL PBC Study, Goet, Jorn C , Bruns, Tony , Carbone, Marco , Verhelst, Xavier , Mason, Andrew L. , Corpechot, Christophe , Invernizzi, Pietro , Battezzati, Pier Maria , Kowdley, Kris V. , Dalekos, George Ν. , Hirschfield, Gideon M. , LaRusso, Nicholas F. , Trivedi, Palak Jitendrakumar , Hansen, Bettina E. , Group, on behalf of the GLOBAL PBC Study

Mayo Clinic

Hepatology | December 9, 2017 | Volume: 67 | Issue: 5 | Pages: 1920-1930

10.1002/hep.29717 | PMID 29220537 Get It

Changes over time in the presenting features and clinical course of patients with primary biliary cholangitis are poorly described. We sought to describe temporal trends in patient and disease characteristics over a 44‐year period across a large international primary biliary cholangitis cohort of 4,805 patients diagnosed between 1970 and 2014, from 17 centers across Europe and North America. Patients were divided into five cohorts according to their year of diagnosis: 1970‐1979 (n = 143), 1980‐1989 (n = 858), 1990‐1999 (n = 1,754), 2000‐2009 (n = 1,815), and ≥2010 (n = 235). Age at diagnosis, disease stage, response to ursodeoxycholic acid, and clinical outcomes were compared. Mean age at diagnosis increased incrementally by 2‐3 years per decade from 46.9 ± 10.1 years in the 1970s to 57.0 ± 12.1 years from 2010 onward (P < 0.001). The female to male ratio (9:1) and antimitochondrial antibody positivity (90%) were not significantly variable. The proportion of patients presenting with mild biochemical disease (according to Rotterdam staging) increased from 41.3% in the 1970s to 72.2% in the 1990s (P < 0.001) and remained relatively stable thereafter. Patients with a mild histological stage at diagnosis increased from 60.4% (1970‐1989) to 76.5% (1990‐2014) (P < 0.001). Correspondingly, response to ursodeoxycholic acid according to Paris‐I criteria increased; 51.7% in the 1970s and 70.5% in the 1990s (P < 0.001). Recent decades were also characterized by lower decompensation rates (18.5% in the 1970s to 5.8% in the 2000s, P < 0.001) and higher 10‐year transplant‐free survival (48.4%, 68.7%, 79.7%, and 80.1% for each respective cohort; P < 0.001). Conclusion: In recent decades, a pattern of primary biliary cholangitis presentation consistent with an older age at diagnosis alongside reduced disease severity has been noted; the observed trends may be explained by an increase in routine testing of liver function and/or a changing environmental trigger. (Hepatology 2018;67:1920‐1930).